Long-term physical activity leads to a significant increase in serum sRAGE levels: a sign of decreased AGE-mediated inflammation due to physical activity?
Authors:
Open Access
- 24 January 2018
- journal article
- research article
- Published by Springer Nature in Heart and Vessels
- Vol. 33 (8) , 893-900
Abstract
There is growing evidence that low levels of the circulating soluble receptor of advanced glycation end products (sRAGE) are a valuable predictor of cardiovascular disease (CVD). The aim of this prospective study was to investigate the influence of long-term physical activity on serum sRAGE levels. 109 subjects were recruited, and 98 completed the study. Participants were asked to perform exercise within the calculated training pulse for 8 months. The performance gain was measured/quantified by bicycle stress tests at the beginning and end of the observation period. sRAGE was measured at baseline and after 2/6/8 months by ELISA. Backwards, multiple linear regression analysis was performed to investigate the association of co-variables age, sex, BMI, and performance at baseline, HbA1c, and lipoprotein a with baseline sRAGE levels. We identified BMI and lipoprotein a as significant predictors for baseline sRAGE levels. Compared to subjects with a performance gain ≤ 4.9% subjects with a gain > 5% showed a significant increase in sRAGE levels up to 22%. sRAGE serum levels correlate negatively with lipoprotein a levels and BMI and long-term physical activity leads to a significant increase in serum sRAGE levels (9–22%), whereby the sRAGE increase is most pronounced in subjects with initially low-performance levels, suggesting that in particular, these subject profit the most from increased physical activity. The sport-mediated increase of sRAGE might be a sign of decreased AGE-mediated inflammation and highlight the protective effect of sports on CVD and other disease which are at least partly mediated by an increased inflammation status.Clinical trials registrationNCT02097199.Keywords
Funding Information
- Federal Ministry of Defence and Sports, Austria (-)
This publication has 26 references indexed in Scilit:
- Low Levels of Serum Soluble Receptors for Advanced Glycation End Products, Biomarkers for Disease State: Myth or RealityInternational Journal of Angiology, 2014
- Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary SyndromePLOS ONE, 2013
- sRAGE and Risk of Diabetes, Cardiovascular Disease, and DeathDiabetes, 2013
- Effects of Exercise on sRAGE Levels and Cardiometabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2012
- Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia–reperfusion injuryAtherosclerosis, 2011
- Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products, and Risk of Colorectal CancerCancer Epidemiology, Biomarkers & Prevention, 2011
- Evidence That Serum Levels of the Soluble Receptor for Advanced Glycation End Products Are Inversely Associated with Pancreatic Cancer Risk: A Prospective StudyCancer Research, 2011
- Influence of Physical Activity Intervention on Circulating Soluble Receptor for Advanced Glycation end Products in Elderly SubjectsJournal of Clinical Medicine Research, 2011
- Dietary Advanced Glycation End Products and AgingNutrients, 2010
- At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End ProductsArteriosclerosis, Thrombosis, and Vascular Biology, 2005